# Horizon Kinetics Holding Corp: Form 10-Q for the period ended Jun 30, 2023

- Company: [Horizon Kinetics Holding Corp](/companies/hkhc.md) (CIK 88000)
- Form: 10-Q
- Filed: 2023-08-14
- Accepted by EDGAR: Aug 14, 2023, 17:14 ET
- Period: 2023-06-30
- Accession: 0000950170-23-042539
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/88000/000095017023042539/slgd-20230630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/88000/000095017023042539/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2023-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2023-04-01 to 2023-06-30 | $1.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months, 2023-01-01 to 2023-06-30 | $3.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2023-04-01 to 2023-06-30 | $824.0k | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2023-01-01 to 2023-06-30 | $1.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2023-04-01 to 2023-06-30 | $714.0k | us-gaap:GrossProfit |
| Gross profit | 6 months, 2023-01-01 to 2023-06-30 | $1.4m | us-gaap:GrossProfit |
| Operating income | 3 months, 2023-04-01 to 2023-06-30 | −$669.0k | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2023-01-01 to 2023-06-30 | −$1.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2023-04-01 to 2023-06-30 | $6.0k | us-gaap:InterestExpense |
| Interest expense | 6 months, 2023-01-01 to 2023-06-30 | $113.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2023-04-01 to 2023-06-30 | $6.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2023-01-01 to 2023-06-30 | $2.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2023-04-01 to 2023-06-30 | −$453.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months, 2023-01-01 to 2023-06-30 | −$84.0k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2023-04-01 to 2023-06-30 | −$0.03 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2023-04-01 to 2023-06-30 | −$0.03 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2023-04-01 to 2023-06-30 | 12,908,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2023-01-01 to 2023-06-30 | 12,853,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2023-01-01 to 2023-06-30 | $907.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2023-06-30 | $608.0k | us-gaap:Cash |
| Current assets | at 2023-06-30 | $4.9m | us-gaap:AssetsCurrent |
| Total assets | at 2023-06-30 | $8.1m | us-gaap:Assets |
| Current liabilities | at 2023-06-30 | $2.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2023-06-30 | $5.3m | us-gaap:Liabilities |
| Current portion of debt | at 2023-06-30 | $1.2m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2023-06-30 | $2.8m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 14,063 characters.

Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with the Company’s Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2022. This Item 2 contains forward-looking statements. The matters discussed in these forward-looking statements are subject to risk, uncertainties, and other factors that could cause actual results to differ materially from those made, projected, or implied in the forward-looking statements. Please refer to "Item 1A. Risk Factors" in this Report and in our Annual Report on Form 10-K for the year ended December 31, 2022 for a discussion of the uncertainties, risks and assumptions associated with these statements.

### Executive Overview

#### Our Business

Scott’s Liquid Gold-Inc. exists to positively impact consumers’ lives in the markets we serve while creating shareholder value. We develop, market, and sell high-quality, high-value household and health and beauty care products nationally and internationally to mass merchandisers, drugstores, supermarkets, hardware stores, e-commerce retailers, other retail outlets, and to wholesale distributors.

Primarily due to a decline in net sales, disruption of our international sales to China, and increases in costs associated with the manufacture and distribution of our products, the Company has experienced negative cash flows from operations for several reporting periods. In efforts to improve our financial position and liquidity, the Company has pursued asset sales of certain brands where management has determined that the brand(s) are not aligned with our long-term goals for growth and profitability. The Company will continue to consider a wide range of options, including one or more of the following: the sale of additional brands; a sale, merger, or other strategic transaction involving the entire company; acquisitions of other brands or companies; issuance of additional debt or equity; and continuing to operate as a public, independent company.

### Divestitures

Closed in July 2023 and effective June 30, 2023, we sold the Alpha® Skin Care product line to a company that markets and distributes skin care products. Closed in July 2023 and effective June 30, 2023, we sold the BIZ® product line to a company that markets and distributes laundry products. The assets of Alpha® and BIZ® are classified as assets held for sale as of June 30, 2023 and December 31, 2022, and their operations have been classified as income from discontinued operations for all periods presented. On January 23, 2023, we sold the Scott's Liquid Gold® Wood Care and Scott's Liquid Gold® Floor Restore product lines to a company that markets and distributes wood care products. On December 15, 2022, we sold the Prell® brand to a company that markets and distributes natural hair and skincare products. We have reflected the operations of Scott's Liquid Gold® and Prell® as discontinued operations for all periods presented.

See Note 3 - “Discontinued Operations and Assets Held for Sale” in the Notes to Condensed Consolidated Financial Statements for further information on the sale of these brands.

In conjunction with the sale of the Scott’s Liquid Gold® brand, as discussed below, the Company may continue to use names “Scott’s Liquid Gold” and “SLG” for up to one year following the closing date of the agreement on January 23, 2023. Following this transitional name period, the Company will only be able to use the aforementioned names in connection with retaining records and other historical or archived documents and any use required by or permitted as a fair use or otherwise under applicable law.

### Results of Operations

#### Three months ended June 30, 2023 compared to three months ended June 30, 2022

|  | Three Months Ended June 30, (in thousands) 2023 | 2022 | Increase / (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $1,538 | $1,120 | $418 | 37.3% |
| Cost of sales | 824 | 737 | 87 | 11.8% |
| Gross profit | 714 | 383 | 331 | 86.4% |
| Gross margin | 46.4% | 34.2% |  |  |
| Operating expenses: |  |  |  |  |
| Advertising | 120 | 174 | (54) | (31.0%) |
| Selling | 574 | 867 | (293) | (33.8%) |
| General and administrative | 638 | 776 | (138) | (17.8%) |
| Intangible asset amortization | 51 | 103 | (52) | (50.5%) |
| Impairment of goodwill and intangible assets | - | 3,589 | (3,589) | (100.0%) |
| Total operating expenses | 1,383 | 5,509 | (4,126) | (74.9%) |
| Loss from operations | (669) | (5,126) | 4,457 | 86.9% |
| Interest expense | (6) | (18) | 12 | 66.7% |
| Loss before income taxes and discontinued operations | (675) | (5,144) | 4,469 | 86.9% |
| Income tax expense | (6) | (52) | 46 | 88.5% |
| Loss from continuing operations | (681) | (5,196) | 4,515 | 86.9% |
| Income from discontinued operations | 228 | 863 | (635) | (73.6%) |
| Net loss | $(453) | $(4,333) | $3,880 | 89.5% |

Our operating results were primarily impacted by the following:

- Increases in net sales, cost of sales, and gross profit are due to increased distribution of our products sold at existing and certain new customers.
- Decrease in selling expenses is primarily due to lower logistics and warehousing costs from a consolidation of our third-party logistics partners, and a reduction in personnel costs related to asset divestitures.
- Decreased general and administrative costs primarily due to a reduction in legal and professional fees, lower bank charges from the termination of our UMB Loan Agreement, and reduced personnel costs.
- Decreased intangible asset amortization from reduced carrying amounts related to impairments recognized in 2022.
- Results from discontinued operations, which are disclosed in Note 3 to the Condensed Consolidated Financial Statements.

### Segment Results

#### Household products

The following table shows comparative net sales, gross margin, gross profit, income or loss from operations, volume, and percentage changes for household products between periods:

|  | Three Months Ended June 30, (in thousands) 2023 | 2022 | Increase / (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $847 | $692 | $155 | 22.4% |
| Gross profit | $392 | $186 | $206 | 110.8% |
| Gross margin | 46.3% | 26.9% |  |  |
| Loss from operations | $(527) | $(4,567) | $4,040 | 88.5% |

- Net sales and gross profit increased due to additional sales of Kids N Pets® and Messy Pet® products to existing customers.
- Loss from operations improved primarily due to decreased selling expenses from the consolidation of our third-party logistics partners. Our loss from operations in the second quarter of 2022 was impacted by the impairment of goodwill and intangible assets associated with our All-Purpose reporting unit.

#### Health and beauty care products

The following table shows comparative net sales, gross margin, gross profit, income or loss from operations, volume and percentage changes for health and beauty care products between periods:

|  | Three Months Ended June 30, (in thousands) 2023 | 2022 | Increase / (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $691 | $428 | $263 | 61.4% |
| Gross profit | $322 | $197 | $125 | 63.6% |
| Gross margin | 46.7% | 46.0% |  |  |
| Loss from operations | $(142) | $(559) | $417 | 74.6% |

- Net sales and gross profits increased due to additional sales of Denorex® to existing customers as well as sales growth to certain new customers.
- Income from operations resulted from decreased selling expenses from the consolidation of our third-party logistics partners as well as a reduction in personnel costs.

#### Six months ended June 30, 2023 compared to six months ended June 30, 2022

|  | Six Months Ended June 30, (in thousands) 2023 | 2022 | Increase / (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $3,268 | $2,928 | $340 | 11.6% |
| Cost of sales | 1,826 | 1,599 | 227 | 14.2% |
| Gross profit | 1,442 | 1,329 | 113 | 8.5% |
| Gross margin | 44.1% | 45.4% |  |  |
| Operating expenses: |  |  |  |  |
| Advertising | 275 | 326 | (51) | (15.6%) |
| Selling | 1,146 | 1,970 | (824) | (41.8%) |
| General and administrative | 1,255 | 1,561 | (306) | (19.6%) |
| Intangible asset amortization | 101 | 226 | (125) | (55.3%) |
| Impairment of goodwill and intangible assets | - | 3,589 | (3,589) | (100.0%) |
| Total operating expenses | 2,777 | 7,672 | (4,895) | (63.8%) |
| Loss from operations | (1,335) | (6,343) | 5,008 | 79.0% |
| Interest expense | (113) | (57) | (56) | (98.2%) |
| Loss before income taxes and discontinued operations | (1,448) | (6,400) | 4,952 | 77.4% |
| Income tax expense | (2) | (52) | 50 | 96.2% |
| Loss from continuing operations | (1,450) | (6,452) | 5,002 | 77.5% |
| Income from discontinued operations | 1,366 | 1,668 | (302) | (18.1%) |
| Net loss | $(84) | $(4,784) | $4,700 | 98.2% |

Our operating results were primarily impacted by the following:

- Increases in net sales, cost of sales, and gross profit are due to increased distribution of our products sold at existing and certain new customers.
- Decrease in selling expenses is primarily due to lower logistics and warehousing costs from a consolidation of our third-party logistics partners, and a reduction in personnel costs related to asset divestitures.
- Decreased general and administrative costs primarily due to a reduction in legal and professional fees, lower bank charges from the termination of our UMB Loan Agreement, and reduced personnel costs.
- Decreased intangible asset amortization from reduced carrying amounts related to impairments recognized in 2022.
- Results from discontinued operations, which are disclosed in Note 3 to the Condensed Consolidated Financial Statements.

### Segment Results

#### Household products

The following table shows comparative net sales, gross margin, gross profit, income or loss from operations, volume, and percentage changes for household products between periods:

|  | Six Months Ended June 30, (in thousands) 2023 | 2022 | Increase / (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $1,669 | $1,619 | $50 | 3.1% |
| Gross profit | $728 | $624 | $104 | 16.7% |
| Gross margin | 43.6% | 38.5% |  |  |
| Loss from operations | $(1,049) | $(5,313) | $4,264 | 80.3% |

- Net sales and gross profit increased due to additional sales of Kids N Pets® and Messy Pet® products to existing customers. Gross margins improved due to impairments of inventories that occurred during the second quarter of 2022.
- Loss from operations improved primarily due to decreased selling expenses from the consolidation of our third-party logistics partners. Our loss from operations in the second quarter of 2022 was impacted by the impairment of goodwill and intangible assets associated with our All-Purpose reporting unit.

#### Health and beauty care products

The following table shows comparative net sales, gross margin, gross profit, income or loss from operations, volume and percentage changes for health and beauty care products between periods:

|  | Six Months Ended June 30, (in thousands) 2023 | 2022 | Increase / (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Net sales | $1,599 | $1,309 | 290 | 22.1% |
| Gross profit | $714 | $705 | $9 | 1.2% |
| Gross margin | 44.6% | 53.9% |  |  |
| Loss from operations | $(286) | $(1,030) | $744 | 72.2% |

- Net sales increased due to additional sales of Denorex® to existing customers as well as sales growth to certain new customers. Gross margin decreased due to rising costs of products, inventory impairments, and the sales mix of products sold to certain customers.
- Loss from operations resulted from decreased selling expenses from the consolidation of our third-party logistics partners as well as a reduction in personnel costs.

### Liquidity and Capital Resources

#### Overview

Our primary sources of funds include cash expected to be generated from operations and sale of brands. Our principal uses of cash are to fund planned operating expenditures. Working capital movements are influenced by the sourcing of materials related to the production of products.

#### Financing Agreements

Please see Note 8 to our Condensed Consolidated Financial Statements for information on our La Plata Loan Agreement, which was terminated in July 2023, and our UMB Loan Agreement, which was terminated in February 2023.

#### Liquidity and Changes in Cash Flows

At June 30, 2023, we had approximately $608 in cash on hand, an increase of $559 from December 31, 2022.

The following is a summary of cash provided by or (used in) each of the indicated types of activities:

|  | Six Months Ended June 30, (in thousands) 2023 | 2022 | Increase / (Decrease) $% |  |
| --- | ---: | ---: | ---: | ---: |
| Operating activities | $907 | $466 | $441 | 94.6% |
| Investing activities | 1,936 | (142) | 2,078 | 1,463.4% |
| Financing activities | (2,284) | (1,278) | (1,006) | (78.7%) |

- Net cash provided by operating activities was primarily related to conversion of working capital from accounts receivable and inventories.
- Net cash provided by investing activities was due to the sale of our Scott's Liquid Gold® brand.
- Net cash used in financing activities was from repayments and termination of our UMB Loan Agreement and offset by proceeds from our La Plata Loan Agreement.

The cash received from the sales of our BIZ® and Alpha® Skin Care brands in July and August 2023 was $3,700 and was partially used to pay off and terminate our La Plata Loan Agreement. While we believe that our current cash reserves represent sufficient cash flows to fund our operations, our liquidity has been affected by inflationary pressures at our customers which have caused sales decreases and higher costs on materials, logistics, and other purchases. We expect that our current cash reserves will be sufficient to meet operational cash needs during the next twelve months, but further economic impacts to our sales to customers or supply chain disruptions in the short-term could impact our liquidity.

## Controls and procedures

As filed, 2,449 characters.

### Disclosure Controls and Procedures

As of June 30, 2023, we conducted an evaluation, under the supervision and with the participation of our President and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended). Based on that evaluation, our President and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of June 30, 2023 due to a material weakness in our internal controls resulting from our finance department not being able to process and account for complex, non-routine transactions in accordance with GAAP. Management concluded that we lack a sufficient number of trained professionals with technical accounting expertise to process and account for complex and non-routine transactions.

#### Remediation Plan

We are committed to maintaining a strong internal control environment and we are developing a remediation plan designed to help ensure that this material weakness is remediated as soon as possible, by establishing internal control(s) to identify complex, non-routine accounting transactions and engaging the assistance of accounting expert(s) as needed to assist in the accounting and reporting of these transactions.

The material weakness will not be considered remediated until a sustained period of time has passed to allow management to test the design and operational effectiveness of the corrective actions. Until the material weakness is remediated, we plan to continue to perform additional analyses and other procedures to ensure that our Condensed Consolidated Financial Statements are prepared in accordance with GAAP.

Notwithstanding such material weakness in internal control over financial reporting, our President and Chief Financial Officer have concluded that the Condensed Consolidated Financial Statements in Part I, Item 1 of this report, present fairly, in all material respects, our financial position, results of operations, and cash flows for the periods presented in conformity with GAAP.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting during the three months ended June 30, 2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 1,444 characters.

**We have identified a material weakness in our internal control over financial reporting.**

We are a public reporting company subject to the rules and regulations established from time to time by the SEC. As a public company we are required to document and test our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act so that our management can certify as to the effectiveness of our internal control over financial reporting.

As disclosed in Part I, Item 4, “Disclosure Controls and Procedures,” we have identified a material weakness in our controls related to our finance department lacking a sufficient number of trained professionals with technical accounting expertise to process and account for complex, non-routine transactions in accordance with GAAP as of June 30, 2023.

This material weakness did not result in any restatements to our Condensed Consolidated Financial Statements. Our management is committed to remediating this material weakness and is in the process of developing a remediation plan to address the material weakness.

In addition to the other information set forth in this Report, you should carefully consider the factors discussed in Item 1A, “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent quarterly reports on Form 10-Q, which could materially affect our business, financial condition, or future results.

Filed Aug 14, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-042539. Last ingested by Listed: Nov 13, 2026, 16:01 ET. No prices; not investment advice.
